Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Researchers analyzed 175 health outcomes and found benefits in 42, including reduced risks of Alzheimers disease, addiction, infections, respiratory failure, clotting disorders, stroke and heart disease
The GLP-1 pill is still prescription-only, but the new form of the pill can make it more easily accessible and easier to take than the once-weekly or once-monthly injection
Key proof-of-principal study that shows that continuous subcutaneous infusion of GLP-1 improves glycaemic control in patients with T2DM
Future perspectives Currently, there is not enough data from randomized placebo-controlled trials in patients with IBD to determine the efficiency of GLPs in this disease
